InflaRx (IFRX) Cost of Revenue (2018 - 2026)

InflaRx has reported Cost of Revenue for 6 years, with the latest figure at $10877.4 in Q1 2026.

• Quarterly Cost of Revenue fell 100.0% year-over-year to $10877.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $397.7 million (down 95.93% YoY) and the FY2025 annual result came in at $8.2 million, up 128.71% from the prior year.
• Cost of Revenue slipped to $10877.4 in Q1 2026 per IFRX's latest filing, from $5.7 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $9.8 billion in Q1 2025 and troughed at $10877.4 in Q1 2026.
• A 4-year average of $925.0 million and a median of $374921.6 in 2024 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2025 and 2026: Cost of Revenue jumped 4079391.8% in 2025, then sank 100.0% in 2026.
• Over 4 years, Cost of Revenue stood at $298192.4 in 2023, then soared by 910.9% to $3.0 million in 2024, then jumped by 87.61% to $5.7 million in 2025, then tumbled by 99.81% to $10877.4 in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $10877.4, $5.7 million, and $389.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.